{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:27:49Z","timestamp":1778736469350,"version":"3.51.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007197","name":"USPHS","doi-asserted-by":"crossref","award":["DK 80984"],"award-info":[{"award-number":["DK 80984"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018497","name":"Children's Discovery and Innovation Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018497","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Casey Lee Ball Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00467-017-3798-x","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T11:26:38Z","timestamp":1506079598000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Nadine","family":"Khouzam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Wesseling-Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"3798_CR1","unstructured":"USRD System (2016) Annual Report, https:\/\/www.usrds.org\/adr.aspx"},{"key":"3798_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.ackd.2005.07.005","volume":"12","author":"MM Mitsnefes","year":"2005","unstructured":"Mitsnefes MM (2005) Cardiovascular disease in children with chronic kidney disease. Adv Chronic Kidney Dis 12:397\u2013405","journal-title":"Adv Chronic Kidney Dis"},{"key":"3798_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00467-004-1624-8","volume":"20","author":"JW Groothoff","year":"2005","unstructured":"Groothoff JW, Lilien MR, van de Kar NC, Wolff ED, Davin JC (2005) Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol 20:374\u2013379","journal-title":"Pediatr Nephrol"},{"key":"3798_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1046\/j.1523-1755.2003.00814.x","volume":"63","author":"MP Gruppen","year":"2003","unstructured":"Gruppen MP, Groothoff JW, Prins M, van der WP, Offringa M, Bos WJ, Davin JC, Heymans HS (2003) Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 63:1058\u20131065","journal-title":"Kidney Int"},{"key":"3798_CR5","doi-asserted-by":"publisher","first-page":"c68","DOI":"10.1159\/000097601","volume":"105","author":"L Rees","year":"2007","unstructured":"Rees L, Shroff R, Hutchinson C, Fernando ON, Trompeter RS (2007) Long-term outcome of paediatric renal transplantation: follow-up of 300 children from 1973 to 2000. Nephron Clin Pract 105:c68\u2013c76","journal-title":"Nephron Clin Pract"},{"key":"3798_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology\/American Heart Association Task Force on Practice (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation 129:S1\u201345","journal-title":"Circulation"},{"key":"3798_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238\u2013248","journal-title":"N Engl J Med"},{"key":"3798_CR8","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"GM London","year":"2004","unstructured":"London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943\u20131951","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR9","first-page":"s1","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 76:s1\u2013s130","journal-title":"Kidney Int"},{"key":"3798_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.01090216","volume":"12","author":"F Schaefer","year":"2017","unstructured":"Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, Niemirska A, Sozeri B, Thurn D, Anarat A, Ranchin B, Litwin M, Caliskan S, Candan C, Baskin E, Yilmaz E, Mir S, Kirchner M, Sander A, Haffner D, Melk A, Wuhl E, Shroff R, Querfeld U, Consortium CS (2017) Cardiovascular phenotypes in children with CKD: the 4C study. Clin J Am Soc Nephrol 12:19\u201328","journal-title":"Clin J Am Soc Nephrol"},{"key":"3798_CR11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00467-013-2737-8","volume":"29","author":"GM Barletta","year":"2014","unstructured":"Barletta GM, Flynn J, Mitsnefes M, Samuels J, Friedman LA, Ng D, Cox C, Poffenbarger T, Warady B, Furth S (2014) Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study. Pediatr Nephrol 29:1059\u20131065","journal-title":"Pediatr Nephrol"},{"key":"3798_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1523-1755.2004.00525.x","volume":"65","author":"MM Mitsnefes","year":"2004","unstructured":"Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65:1461\u20131466","journal-title":"Kidney Int"},{"key":"3798_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.CIR.0000049744.23613.69","volume":"107","author":"MM Mitsnefes","year":"2003","unstructured":"Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864\u2013868","journal-title":"Circulation"},{"key":"3798_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2215\/CJN.01230212","volume":"7","author":"M Park","year":"2012","unstructured":"Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA (2012) Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 7:1137\u20131144","journal-title":"Clin J Am Soc Nephrol"},{"key":"3798_CR15","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545\u20132552","journal-title":"Circulation"},{"key":"3798_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamacardio.2016.1445","volume":"1","author":"R Mehta","year":"2016","unstructured":"Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort Study I (2016) Association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease, from the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol 1:548\u2013556","journal-title":"JAMA Cardiol"},{"key":"3798_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","journal-title":"N Engl J Med"},{"key":"3798_CR18","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro OM, Kusek JW, Keane MG, Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408","journal-title":"J Clin Invest"},{"key":"3798_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/kisup.2011.6","volume":"1","author":"D Fliser","year":"2011","unstructured":"Fliser D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Agarwal R, Jager KJ, Dekker FW, Blankestijn PJ, Goldsmith D, Covic A, London G, Zoccali C, for ER, Dialysis CAMwgotERA-E, Transplant A (2011) The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. Kidney Int Suppl 1:6\u20139","journal-title":"Kidney Int Suppl"},{"key":"3798_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.vph.2015.12.004","volume":"81","author":"KJ Quek","year":"2016","unstructured":"Quek KJ, Boyd R, Ameer OZ, Zangerl B, Butlin M, Murphy TV, Avolio AP, Phillips JK (2016) Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease. Vasc Pharmacol 81:42\u201352","journal-title":"Vasc Pharmacol"},{"key":"3798_CR21","first-page":"30","volume":"63","author":"V Shukla","year":"2015","unstructured":"Shukla V, Dey R, Chandra A, Karoli R, Khanduri S (2015) Endothelial dysfunction by flow-mediated vasodilatation in chronic kidney disease. J Assoc Physicians India 63:30\u201333","journal-title":"J Assoc Physicians India"},{"key":"3798_CR22","doi-asserted-by":"publisher","first-page":"e0166050","DOI":"10.1371\/journal.pone.0166050","volume":"11","author":"D Burkhardt","year":"2016","unstructured":"Burkhardt D, Bartosova M, Schaefer B, Grabe N, Lahrmann B, Nasser H, Freise C, Schneider A, Lingnau A, Degenhardt P, Ranchin B, Sallay P, Cerkauskiene R, Malina M, Ariceta G, Schmitt CP, Querfeld U (2016) Reduced microvascular density in omental biopsies of children with chronic kidney disease. PLoS One 11:e0166050","journal-title":"PLoS One"},{"key":"3798_CR23","doi-asserted-by":"publisher","unstructured":"Stevens KK, Denby L, Patel RK, Mark PB, Kettlewell S, Smith GL, Clancy MJ, Delles C, Jardine AG (2016) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfw252","DOI":"10.1093\/ndt\/gfw252"},{"key":"3798_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.amsu.2016.05.017","volume":"9","author":"AE El-Sadek","year":"2016","unstructured":"El-Sadek AE, Behery EG, Azab AA, Kamal NM, Salama MA, Abdulghany WE, Abdallah EA (2016) Arginine dimethylation products in pediatric patients with chronic kidney disease. Ann Med Surg 9:22\u201327","journal-title":"Ann Med Surg"},{"key":"3798_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000322367","volume":"33","author":"A Fujimi-Hayashida","year":"2011","unstructured":"Fujimi-Hayashida A, Ueda S, Yamagishi S, Kaida Y, Ando R, Nakayama Y, Fukami K, Okuda S (2011) Association of asymmetric dimethylarginine with severity of kidney injury and decline in kidney function in IgA nephropathy. Am J Nephrol 33:1\u20136","journal-title":"Am J Nephrol"},{"issue":"4","key":"3798_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/clpt.2010.116","volume":"88","author":"S von Haehling","year":"2010","unstructured":"Von Haehling S, Bode-Boger SM, Martens-Lobenhoffer J, Rauchhaus M, Schefold JC, Genth-Zotz S, Karhausen T, Cicoira M, Anker SD, Doehner W (2010) Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol. Clin Pharmacol Ther 88:506\u2013512","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"3","key":"3798_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5551\/jat.1594","volume":"17","author":"So Kuwahata","year":"2010","unstructured":"Kuwahata S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Orihara K, Ogawa M, Oketani N, Saihara K, Okui H, Shinsato T, Kubozono T, Ichiki H, Fujita S, Takumi T, Yoshino S, Nakazaki M, Miyata M, Tei C (2010) Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA. J Atheroscler Thromb 17:259\u2013269","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"3798_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HJH.0000000000001161","volume":"35","author":"R Lariviere","year":"2017","unstructured":"Lariviere R, Gauthier-Bastien A, Ung RV, St-Hilaire J, Mac-Way F, Richard DE, Agharazii M (2017) Endothelin type a receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease. J Hypertens 35:376\u2013384","journal-title":"J Hypertens"},{"key":"3798_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1113\/jphysiol.2014.283887","volume":"593","author":"A Garcia-Jerez","year":"2015","unstructured":"Garcia-Jerez A, Luengo A, Carracedo J, Ramirez-Chamond R, Rodriguez-Puyol D, Rodriguez-Puyol M, Calleros L (2015) Effect of uraemia on endothelial cell damage is mediated by the integrin linked kinase pathway. J Physiol 593:601\u2013618 discussion 618","journal-title":"J Physiol"},{"key":"3798_CR30","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00424-016-1858-x","volume":"468","author":"B Richter","year":"2016","unstructured":"Richter B, Haller J, Haffner D, Leifheit-Nestler M (2016) Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Pflugers Arch 468:1621\u20131635","journal-title":"Pflugers Arch"},{"key":"3798_CR31","first-page":"358","volume":"22","author":"T Damjanovic","year":"2009","unstructured":"Damjanovic T, Djuric S, Schlieper G, Markovic N, Dimkovic S, Radojicic Z, Kruger T, Floege J, Dimkovic N (2009) Clinical features of hemodialysis patients with intimal versus medial vascular calcifications. J Nephrol 22:358\u2013366","journal-title":"J Nephrol"},{"key":"3798_CR32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ki.1990.293","volume":"38","author":"DS Milliner","year":"1990","unstructured":"Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931\u2013936","journal-title":"Kidney Int"},{"key":"3798_CR33","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483","journal-title":"N Engl J Med"},{"key":"3798_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"3798_CR35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/j.1600-6143.2005.00914.x","volume":"5","author":"MB Ishitani","year":"2005","unstructured":"Ishitani MB, Milliner DS, Kim DY, Bohorquez HE, Heimbach JK, Sheedy PF, Morgenstern BZ, Gloor JM, Murphy JG, McBane RD, Bielak LF, Peyser PA, Stegall MD (2005) Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant 5:1689\u20131693","journal-title":"Am J Transplant"},{"key":"3798_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5301\/jn.5000290","volume":"26","author":"L Di Lullo","year":"2013","unstructured":"Di Lullo L, Floccari F, Santoboni A, Barbera V, Rivera RF, Granata A, Morrone L, Russo D (2013) Progression of cardiac valve calcification and decline of renal function in CKD patients. J Nephrol 26:739\u2013744","journal-title":"J Nephrol"},{"key":"3798_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","volume":"39","author":"P Raggi","year":"2002","unstructured":"Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695\u2013701","journal-title":"J Am Coll Cardiol"},{"key":"3798_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ajkd.2006.12.017","volume":"49","author":"S Okuno","year":"2007","unstructured":"Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y (2007) Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 49:417\u2013425","journal-title":"Am J Kidney Dis"},{"key":"3798_CR39","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","volume":"63","author":"SM Moe","year":"2003","unstructured":"Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003\u20131011","journal-title":"Kidney Int"},{"key":"3798_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"SM Moe","year":"2002","unstructured":"Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638\u2013647","journal-title":"Kidney Int"},{"key":"3798_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/ASN.2009060640","volume":"21","author":"RC Shroff","year":"2010","unstructured":"Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM (2010) Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 21:103\u2013112","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR42","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.1276205","volume":"19","author":"M Murshed","year":"2005","unstructured":"Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093\u20131104","journal-title":"Genes Dev"},{"key":"3798_CR43","doi-asserted-by":"publisher","first-page":"e6666","DOI":"10.1097\/MD.0000000000006666","volume":"96","author":"E Bae","year":"2017","unstructured":"Bae E, Cha RH, Kim YC, An JN, Kim DK, Yoo KD, Lee SM, Kim MH, Park JT, Kang SW, Park JY, Lim CS, Kim YS, Yang SH, Lee JP (2017) Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease. Medicine 96:e6666","journal-title":"Medicine"},{"key":"3798_CR44","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","volume":"37","author":"S Ahmed","year":"2001","unstructured":"Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM (2001) Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37:1267\u20131276","journal-title":"Am J Kidney Dis"},{"key":"3798_CR45","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/sj.ki.5002353","volume":"72","author":"E Neven","year":"2007","unstructured":"Neven E, Dauwe S, De Broe ME, D'Haese PC, Persy V (2007) Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int 72:574\u2013581","journal-title":"Kidney Int"},{"key":"3798_CR46","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/01.ATV.0000220441.42041.20","volume":"26","author":"JS Shao","year":"2006","unstructured":"Shao JS, Cai J, Towler DA (2006) Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26:1423\u20131430","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3798_CR47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"SA Steitz","year":"2001","unstructured":"Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89:1147\u20131154","journal-title":"Circ Res"},{"key":"3798_CR48","doi-asserted-by":"publisher","first-page":"14063","DOI":"10.1074\/jbc.M707390200","volume":"283","author":"KP Hanley","year":"2008","unstructured":"Hanley KP, Oakley F, Sugden S, Wilson DI, Mann DA, Hanley NA (2008) Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 283:14063\u201314071","journal-title":"J Biol Chem"},{"key":"3798_CR49","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2005.06.119","volume":"334","author":"A Simionescu","year":"2005","unstructured":"Simionescu A, Philips K, Vyavahare N (2005) Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 334:524\u2013532","journal-title":"Biochem Biophys Res Commun"},{"key":"3798_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2353\/ajpath.2007.060930","volume":"171","author":"A Simionescu","year":"2007","unstructured":"Simionescu A, Simionescu DT, Vyavahare NR (2007) Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol 171:116\u2013123","journal-title":"Am J Pathol"},{"key":"3798_CR51","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1073\/pnas.95.12.6983","volume":"95","author":"AH Schulick","year":"1998","unstructured":"Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA (1998) Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A 95:6983\u20136988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3798_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2215\/CJN.01760506","volume":"2","author":"ML Gross","year":"2007","unstructured":"Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, Berger I, Adamczak M, Schirmacher P, Ritz E (2007) Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2:121\u2013134","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3798_CR53","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/bio.3302","volume":"32","author":"Qingfeng Zhang","year":"2017","unstructured":"Zhang Q, Zhang C, Yang M, Yu D, Yu C (2017) Pyrophosphate as substrate for alkaline phosphatase activity: a convenient flow-injection chemiluminescence assay. Luminescence. https:\/\/doi.org\/10.1002\/bio.3302","journal-title":"Luminescence"},{"key":"3798_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cardiores.2005.01.012","volume":"66","author":"HH Dao","year":"2005","unstructured":"Dao HH, Essalihi R, Bouvet C, Moreau P (2005) Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 66:307\u2013317","journal-title":"Cardiovasc Res"},{"key":"3798_CR55","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","volume":"100","author":"CM Shanahan","year":"1999","unstructured":"Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168\u20132176","journal-title":"Circulation"},{"key":"3798_CR56","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ki.2013.521","volume":"85","author":"KA Lomashvili","year":"2014","unstructured":"Lomashvili KA, Narisawa S, Millan JL, O'Neill WC (2014) Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int 85:1351\u20131356","journal-title":"Kidney Int"},{"key":"3798_CR57","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li X, Yang HY, Giachelli CM (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98:905\u2013912","journal-title":"Circ Res"},{"key":"3798_CR58","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/ndt\/gfk008","volume":"21","author":"M Mizobuchi","year":"2006","unstructured":"Mizobuchi M, Ogata H, Hatamura I, Koiwa F, Saji F, Shiizaki K, Negi S, Kinugasa E, Ooshima A, Koshikawa S, Akizawa T (2006) Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. Nephrol Dial Transplant 21:911\u2013916","journal-title":"Nephrol Dial Transplant"},{"key":"3798_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000453368","volume":"135","author":"S Thamratnopkoon","year":"2017","unstructured":"Thamratnopkoon S, Susantitaphong P, Tumkosit M, Katavetin P, Tiranathanagul K, Praditpornsilpa K, Eiam-Ong S (2017) Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron 135:167\u2013172","journal-title":"Nephron"},{"key":"3798_CR60","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1681\/ASN.2016060651","volume":"28","author":"SU Nigwekar","year":"2017","unstructured":"Nigwekar SU, Bloch DB, Nazarian RM, Vermeer C, Booth SL, Xu D, Thadhani RI, Malhotra R (2017) Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis. J Am Soc Nephrol 28:1717\u20131722","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR61","doi-asserted-by":"publisher","unstructured":"Han KH, O'Neill WC (2016) Increased peripheral arterial calcification in patients receiving warfarin. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.115.002665","DOI":"10.1161\/JAHA.115.002665"},{"key":"3798_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jcmm.12373","volume":"19","author":"D Zhu","year":"2015","unstructured":"Zhu D, Mackenzie NC, Shanahan CM, Shroff RC, Farquharson C, MacRae VE (2015) BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway. J Cell Mol Med 19:165\u2013174","journal-title":"J Cell Mol Med"},{"key":"3798_CR63","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, Freedman BI, Monier-Faugere MC, Malluche H, Hruska KA (2014) CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25:1760\u20131773","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR64","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","volume":"44","author":"D Russo","year":"2004","unstructured":"Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE (2004) Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44:1024\u20131030","journal-title":"Am J Kidney Dis"},{"key":"3798_CR65","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"key":"3798_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","volume":"204","author":"A Van Campenhout","year":"2009","unstructured":"Van Campenhout A, Golledge J (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204:321\u2013329","journal-title":"Atherosclerosis"},{"key":"3798_CR67","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","volume":"27","author":"ER Smith","year":"2012","unstructured":"Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG (2012) Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 27:1957\u20131966","journal-title":"Nephrol Dial Transplant"},{"key":"3798_CR68","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131\u20132138","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR69","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/ndt\/gfn571","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 24:948\u2013955","journal-title":"Nephrol Dial Transplant"},{"key":"3798_CR70","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00467-011-1822-0","volume":"26","author":"PR Srivaths","year":"2011","unstructured":"Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED (2011) Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol 26:945\u2013951","journal-title":"Pediatr Nephrol"},{"key":"3798_CR71","doi-asserted-by":"crossref","unstructured":"Van Venrooij NA, Pereira RC, Tintut Y, Fishbein MC, Tumber N, Demer LL, Salusky IB, Wesseling-Perry K (2014) FGF23 protein expression in coronary arteries is associated with impaired kidney function. Nephrol Dial Transplant 29:1525\u20131532","DOI":"10.1093\/ndt\/gft523"},{"key":"3798_CR72","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, Kallem RR, Chen J, Lash JP, Kusek JW, Budoff MJ, Giachelli CM, Wolf M (2013) Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83:1159\u20131168","journal-title":"Kidney Int"},{"key":"3798_CR73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bone.2015.10.008","volume":"83","author":"D Mattinzoli","year":"2016","unstructured":"Mattinzoli D, Rastaldi MP, Ikehata M, Armelloni S, Pignatari C, Giardino LA, Li M, Alfieri CM, Regalia A, Riccardi D, Messa P (2016) FGF23-regulated production of Fetuin-A (AHSG) in osteocytes. Bone 83:35\u201347","journal-title":"Bone"},{"key":"3798_CR74","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124\u2013136","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2215\/CJN.08420811","volume":"8","author":"MC Matteucci","year":"2013","unstructured":"Matteucci MC, Chinali M, Rinelli G, Wuhl E, Zurowska A, Charbit M, Pongiglione G, Schaefer F, Group ET (2013) Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin J Am Soc Nephrol 8:203\u2013210","journal-title":"Clin J Am Soc Nephrol"},{"key":"3798_CR76","first-page":"150","volume":"45","author":"A Nursalim","year":"2013","unstructured":"Nursalim A, Siregar P, Widyahening IS (2013) Effect of folic acid, vitamin B6 and vitamin B12 supplementation on mortality and cardiovascular complication among patients with chronic kidney disease: an evidence-based case report. Acta Med Indones 45:150\u2013156","journal-title":"Acta Med Indones"},{"key":"3798_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.ajkd.2016.01.019","volume":"68","author":"T Dad","year":"2016","unstructured":"Dad T, Tighiouart H, Joseph A, Bostom A, Carpenter M, Hunsicker L, Kusek JW, Pfeffer M, Levey AS, Weiner DE (2016) Aspirin use and incident cardiovascular disease, kidney failure, and death in stable kidney transplant recipients: a post hoc analysis of the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial. Am J Kidney Dis 68:277\u2013286","journal-title":"Am J Kidney Dis"},{"key":"3798_CR78","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","volume":"356","author":"M Boaz","year":"2000","unstructured":"Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213\u20131218","journal-title":"Lancet"},{"key":"3798_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1574887110666151026123235","volume":"11","author":"M Nataatmadja","year":"2016","unstructured":"Nataatmadja M, Cho Y, Fahim M, Johnson DW (2016) Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease: an update. Rev Recent Clin Trials 11:12\u201332","journal-title":"Rev Recent Clin Trials"},{"key":"3798_CR80","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","volume":"368","author":"D Heyland","year":"2013","unstructured":"Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, Canadian Critical Care Trials Group (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:1489\u20131497","journal-title":"N Engl J Med"},{"key":"3798_CR81","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1681\/ASN.2005070779","volume":"16","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G (2005) Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol 16:3748\u20133754","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR82","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","volume":"60","author":"M Jun","year":"2012","unstructured":"Jun M, Zhu B, Tonelli M, Jardine MJ, Patel A, Neal B, Liyanage T, Keech A, Cass A, Perkovic V (2012) Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol 60:2061\u20132071","journal-title":"J Am Coll Cardiol"},{"key":"3798_CR83","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ki.2012.403","volume":"83","author":"KM Hill","year":"2013","unstructured":"Hill KM, Martin BR, Wastney ME, McCabe GP, Moe SM, Weaver CM, Peacock M (2013) Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 83:959\u2013966","journal-title":"Kidney Int"},{"key":"3798_CR84","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1681\/ASN.2012030223","volume":"23","author":"GA Block","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM (2012) Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23:1407\u20131405","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR85","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","volume":"68","author":"E Slatopolsky","year":"2005","unstructured":"Slatopolsky E, Liapis H, Finch J (2005) Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int 68:2809\u20132813","journal-title":"Kidney Int"},{"key":"3798_CR86","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","volume":"21","author":"GB Spasovski","year":"2006","unstructured":"Spasovski GB, Sikole A, Gelev S, Masin-Spasovska J, Freemont T, Webster I, Gill M, Jones C, De Broe ME, D'Haese PC (2006) Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant 21:2217\u20132224","journal-title":"Nephrol Dial Transplant"},{"key":"3798_CR87","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382:1268\u20131277","journal-title":"Lancet"},{"key":"3798_CR88","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela AL, Graciolli FG, dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moyses RM (2010) Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5:286\u2013291","journal-title":"Clin J Am Soc Nephrol"},{"key":"3798_CR89","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova T, Gutierrez OM, Smith K, Epstein M, Keating LK, Juppner H, Wolf M (2011) Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 26:584\u2013591","journal-title":"Nephrol Dial Transplant"},{"key":"3798_CR90","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2215\/CJN.05170513","volume":"9","author":"K Yokoyama","year":"2014","unstructured":"Yokoyama K, Hirakata H, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Block GA (2014) Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. Clin J Am Soc Nephrol 9:543\u2013552","journal-title":"Clin J Am Soc Nephrol"},{"key":"3798_CR91","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC, Allen MR, Robling AG, Stayrook KR, Jideonwo V, Magers MJ, Garringer HJ, Vidal R, Chan RJ, Goodwin CB, Hui SL, Peacock M, White KE (2011) Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A 108:E1146\u2013E1155","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3798_CR92","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.04760511","volume":"7","author":"R Shroff","year":"2012","unstructured":"Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, Wells D, Aitkenhead H, Manickavasagar B, van't Hoff W, Rees L (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 7:216\u2013223","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"3798_CR93","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1681\/ASN.2017010003","volume":"28","author":"Vivek Kumar","year":"2017","unstructured":"Kumar V, Yadav AK, Lal A, Kumar V, Singhal M, Billot L, Gupta KL, Banerjee D, Jha V (2017) A randomized trial of vitamin D supplementation on vascular function in CKD. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2017010003","journal-title":"Journal of the American Society of Nephrology"},{"key":"3798_CR94","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1681\/ASN.2004070573","volume":"16","author":"M Teng","year":"2005","unstructured":"Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115\u20131125","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR95","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771\u2013780","journal-title":"Kidney Int"},{"key":"3798_CR96","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1056\/NEJMoa022536","volume":"349","author":"M Teng","year":"2003","unstructured":"Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446\u2013456","journal-title":"N Engl J Med"},{"key":"3798_CR97","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1681\/ASN.2007091002","volume":"19","author":"M Wolf","year":"2008","unstructured":"Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19:1379\u20131388","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR98","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","volume":"164","author":"H Tamez","year":"2012","unstructured":"Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E, Pritchett Y, Chang Y, Agarwal R, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Singh B, Zehnder D, Pachika A, Manning WJ, Shah A, Solomon SD, Thadhani R (2012) Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J 164:902\u2013909.e2","journal-title":"Am Heart J"},{"key":"3798_CR99","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cvr\/cvn279","volume":"81","author":"MU Alam","year":"2009","unstructured":"Alam MU, Kirton JP, Wilkinson FL, Towers E, Sinha S, Rouhi M, Vizard TN, Sage AP, Martin D, Ward DT, Alexander MY, Riccardi D, Canfield AE (2009) Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 81:260\u2013268","journal-title":"Cardiovasc Res"},{"key":"3798_CR100","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Floege J (2011) The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26:1327\u20131339","journal-title":"Nephrol Dial Transplant"},{"key":"3798_CR101","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793\u20131800","journal-title":"Kidney Int"},{"key":"3798_CR102","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2369-14-112","volume":"14","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kim H, Shin N, Na KY, Kim YL, Kim D, Chang JH, Song YR, Hwang YH, Kim YS, Ahn C, Lee J, Oh KH, Representing the Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect Of iPTH Level (CUPID) Study Group (2013) Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study. BMC Nephrol 14:112","journal-title":"BMC Nephrol"},{"issue":"1","key":"3798_CR103","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"Sharon M. Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drueke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators (2015) Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation 132:27\u201339","journal-title":"Circulation"},{"key":"3798_CR104","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"GM Chertow","year":"2012","unstructured":"Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482\u20132494","journal-title":"N Engl J Med"},{"key":"3798_CR105","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1681\/ASN.2004110932","volume":"16","author":"M Litwin","year":"2005","unstructured":"Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494\u20131500","journal-title":"J Am Soc Nephrol"},{"key":"3798_CR106","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/01.CIR.0000133412.53089.26","volume":"110","author":"MM Mitsnefes","year":"2004","unstructured":"Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 110:97\u2013101","journal-title":"Circulation"},{"key":"3798_CR107","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1399-3046.2011.01547.x","volume":"15","author":"R Balzano","year":"2011","unstructured":"Balzano R, Lindblad YT, Vavilis G, Jogestrand T, Berg UB, Krmar RT (2011) Use of annual ABPM, and repeated carotid scan and echocardiography to monitor cardiovascular health over nine yr in pediatric and young adult renal transplant recipients. Pediatr Transplant 15:635\u2013641","journal-title":"Pediatr Transplant"},{"key":"3798_CR108","first-page":"410","volume":"12","author":"RT Kmar","year":"2008","unstructured":"Kmar RT, Balzano R, Jogestrand T, Cedazo-Minguez A, Englund MD, Breg UB (2008) Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotensin and in treated hypertensive receipients. Pediatr Transplant 12:410\u2013419","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-017-3798-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3798-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3798-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:03:56Z","timestamp":1650326636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-017-3798-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3798"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3798-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}